CHEMISTRY AND MOLECULAR-BIOLOGY OF PLATINUM ANTICANCER DRUGS

[61] ROBERTS JJ, 1987, CANCER RES, V47, P31

[62] CROSSLINKING OF COMPLEMENTARY STRANDS OF DNA IN MAMMALIAN-CELLS BY ANTITUMOR PLATINUM COMPOUNDS [J]. NATURE, 1972, 235 (5336) : 282 - &

[63] PLATINUM COMPOUNDS - A NEW CLASS OF POTENT ANTITUMOUR AGENTS [J]. NATURE, 1969, 222 (5191) : 385 - +

[64] USE OF EXONUCLEASE-III TO DETERMINE THE SITE OF STABLE LESIONS IN DEFINED SEQUENCES OF DNA - THE CYCLOBUTANE PYRIMIDINE DIMER AND CIS-DICHLORODIAMMINE AND TRANS DICHLORODIAMMINE PLATINUM-II EXAMPLES [J]. NUCLEIC ACIDS RESEARCH, 1981, 9 (18) : 4595 - 4609

[65] SIMILAR BINDING OF THE CARCINOSTATIC DRUGS CIS-[PT(NH3)2CL2] AND [RU(NH3)5CL] CL2 TO TRANSFER RNAPHE AND A COMPARISON WITH THE BINDING OF THE INACTIVE TRANS-[PT(NH3)2CL2] COMPLEX - RELUCTANCE IN BINDING TO WATSON-CRICK BASE-PAIRS WITHIN DOUBLE HELIX [J]. NUCLEIC ACIDS RESEARCH, 1983, 11 (18) : 6571 - 6586

[66] SAENGER W, 1984, PRINCIPLES NUCLEIC A

[67] S1-NUCLEASE SENSITIVITY TO CIS-DIAMMINEDICHLOROPLATINUM(II) AND TRANS-DIAMMINEDICHLOROPLATINUM(II) MODIFIED DNAS - INFLUENCE OF (G+C) CONTENT AND NUCLEOTIDE-SEQUENCE [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 124 (02) : 367 - 374

[68] X-RAY STRUCTURE OF THE MAJOR ADDUCT OF THE ANTICANCER DRUG CISPLATIN WITH DNA - CIS-[PT(NH3)2(D(PGPG))] [J]. SCIENCE, 1985, 230 (4724) : 412 - 417

[69] SPECIFIC BINDING OF ANTITUMOR DRUG CIS-PT(NH3)2CL2 TO DNA RICH IN GUANINE AND CYTOSINE [J]. NATURE, 1974, 251 (5477) : 736 - 737

[70] BINDING OF CIS-DIAMMINEDICHLOROPLATINUM(II) AND TRANS-DIAMMINEDICHLOROPLATINUM(II) TO DEOXYRIBONUCLEIC-ACID EXPOSES NUCLEOSIDES AS MEASURED IMMUNOCHEMICALLY WITH ANTI-NUCLEOSIDE ANTIBODIES [J]. BIOCHEMISTRY, 1986, 25 (07) : 1520 - 1524

[61] ROBERTS JJ, 1987, CANCER RES, V47, P31

[62] CROSSLINKING OF COMPLEMENTARY STRANDS OF DNA IN MAMMALIAN-CELLS BY ANTITUMOR PLATINUM COMPOUNDS [J]. NATURE, 1972, 235 (5336) : 282 - &

[63] PLATINUM COMPOUNDS - A NEW CLASS OF POTENT ANTITUMOUR AGENTS [J]. NATURE, 1969, 222 (5191) : 385 - +

[64] USE OF EXONUCLEASE-III TO DETERMINE THE SITE OF STABLE LESIONS IN DEFINED SEQUENCES OF DNA - THE CYCLOBUTANE PYRIMIDINE DIMER AND CIS-DICHLORODIAMMINE AND TRANS DICHLORODIAMMINE PLATINUM-II EXAMPLES [J]. NUCLEIC ACIDS RESEARCH, 1981, 9 (18) : 4595 - 4609

[65] SIMILAR BINDING OF THE CARCINOSTATIC DRUGS CIS-[PT(NH3)2CL2] AND [RU(NH3)5CL] CL2 TO TRANSFER RNAPHE AND A COMPARISON WITH THE BINDING OF THE INACTIVE TRANS-[PT(NH3)2CL2] COMPLEX - RELUCTANCE IN BINDING TO WATSON-CRICK BASE-PAIRS WITHIN DOUBLE HELIX [J]. NUCLEIC ACIDS RESEARCH, 1983, 11 (18) : 6571 - 6586

[66] SAENGER W, 1984, PRINCIPLES NUCLEIC A

[67] S1-NUCLEASE SENSITIVITY TO CIS-DIAMMINEDICHLOROPLATINUM(II) AND TRANS-DIAMMINEDICHLOROPLATINUM(II) MODIFIED DNAS - INFLUENCE OF (G+C) CONTENT AND NUCLEOTIDE-SEQUENCE [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 124 (02) : 367 - 374

[68] X-RAY STRUCTURE OF THE MAJOR ADDUCT OF THE ANTICANCER DRUG CISPLATIN WITH DNA - CIS-[PT(NH3)2(D(PGPG))] [J]. SCIENCE, 1985, 230 (4724) : 412 - 417

[69] SPECIFIC BINDING OF ANTITUMOR DRUG CIS-PT(NH3)2CL2 TO DNA RICH IN GUANINE AND CYTOSINE [J]. NATURE, 1974, 251 (5477) : 736 - 737

[70] BINDING OF CIS-DIAMMINEDICHLOROPLATINUM(II) AND TRANS-DIAMMINEDICHLOROPLATINUM(II) TO DEOXYRIBONUCLEIC-ACID EXPOSES NUCLEOSIDES AS MEASURED IMMUNOCHEMICALLY WITH ANTI-NUCLEOSIDE ANTIBODIES [J]. BIOCHEMISTRY, 1986, 25 (07) : 1520 - 1524